JNJ-28312141 is an orally active CSF1R inhibitor and a FLT3 inhibitor. JNJ-28312141 is a new agent with potential therapeutic activity in acute myeloid leukemia and in settings where CSF-1-dependent macrophages and osteoclasts contribute to tumor growth and skeletal events.
Molecular Weight:
460.57
CAS Number:
[885692-52-4]
Formula:
C26H32N6O2
Target:
Others|||c-Fms
T21330
* VAT and and shipping costs not included. Errors and price changes excepted